Laurel Wealth Advisors LLC - ESSA PHARMA INC ownership

ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 60 filers reported holding ESSA PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Laurel Wealth Advisors LLC ownership history of ESSA PHARMA INC
ValueSharesWeighting
Q3 2023$1,854
+14.4%
6000.0%0.00%
Q2 2023$1,620
-9.1%
6000.0%0.00%
Q1 2023$1,782
+17.9%
6000.0%0.00%
Q4 2022$1,512
+51.2%
6000.0%0.00%
Q3 2022$1,000
-50.0%
6000.0%0.00%
Q2 2022$2,000
-50.0%
6000.0%0.00%
-100.0%
Q1 2022$4,000
-55.6%
6000.0%0.00%
-50.0%
Q4 2021$9,000
+80.0%
6000.0%0.00%
+100.0%
Q3 2021$5,000
-70.6%
6000.0%0.00%
-75.0%
Q2 2021$17,0000.0%6000.0%0.00%0.0%
Q1 2021$17,000
+142.9%
6000.0%0.00%
+100.0%
Q4 2020$7,000
+75.0%
6000.0%0.00%
+100.0%
Q3 2020$4,0000.0%6000.0%0.00%0.0%
Q2 2020$4,000
+100.0%
6000.0%0.00%0.0%
Q1 2020$2,000
-33.3%
6000.0%0.00%0.0%
Q4 2019$3,000
+50.0%
6000.0%0.00%0.0%
Q3 2019$2,000
+100.0%
6000.0%0.00%
Q2 2019$1,000
-50.0%
6000.0%0.00%
-100.0%
Q1 2019$2,000
+100.0%
6000.0%0.00%
Q4 2018$1,0006000.00%
Other shareholders
ESSA PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 4,287,094$13,247,1201.22%
BVF INC/IL 8,748,629$27,033,2640.73%
PFM Health Sciences, LP 4,199,253$12,975,6920.61%
Bellevue Group AG 7,898,583$24,406,6210.39%
Rhenman & Partners Asset Management AB 356,500$1,101,5850.12%
Rock Springs Capital Management LP 677,005$2,091,9450.06%
Orbimed Advisors 842,366$2,602,9110.06%
Privium Fund Management (UK) Ltd 20,032$61,0980.05%
Hunting Hill Global Capital, LLC 10,000$30,9000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,042,531$3,221,4210.01%
View complete list of ESSA PHARMA INC shareholders